FR2836914B1 - Indazoles substitues, compositions les contenant, procede de fabrication et utilisation - Google Patents

Indazoles substitues, compositions les contenant, procede de fabrication et utilisation

Info

Publication number
FR2836914B1
FR2836914B1 FR0202996A FR0202996A FR2836914B1 FR 2836914 B1 FR2836914 B1 FR 2836914B1 FR 0202996 A FR0202996 A FR 0202996A FR 0202996 A FR0202996 A FR 0202996A FR 2836914 B1 FR2836914 B1 FR 2836914B1
Authority
FR
France
Prior art keywords
manufacture
compositions containing
containing same
substituted indazoles
indazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0202996A
Other languages
English (en)
French (fr)
Other versions
FR2836914A1 (fr
Inventor
Dominique Damour
Corinne Terrier
Patrick Nemecek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to FR0202996A priority Critical patent/FR2836914B1/fr
Priority to GT200300031A priority patent/GT200300031A/es
Priority to PA20038566701A priority patent/PA8566701A1/es
Priority to TW092103799A priority patent/TW200303863A/zh
Priority to SV2003001493A priority patent/SV2003001493A/es
Priority to EP03744395A priority patent/EP1487803A1/fr
Priority to IL16380503A priority patent/IL163805A0/xx
Priority to OA1200400236A priority patent/OA12784A/fr
Priority to CNB038058731A priority patent/CN100369899C/zh
Priority to MXPA04008446A priority patent/MXPA04008446A/es
Priority to HR20040825A priority patent/HRP20040825A2/hr
Priority to AU2003242808A priority patent/AU2003242808B2/en
Priority to BR0308339-0A priority patent/BR0308339A/pt
Priority to JP2003576408A priority patent/JP4643910B2/ja
Priority to PCT/FR2003/000751 priority patent/WO2003078402A1/fr
Priority to CA002478540A priority patent/CA2478540A1/fr
Priority to PE2003000232A priority patent/PE20040071A1/es
Priority to RU2004130280/04A priority patent/RU2004130280A/ru
Priority to PL03372389A priority patent/PL372389A1/xx
Priority to KR10-2004-7014298A priority patent/KR20040091128A/ko
Priority to HN2003000094A priority patent/HN2003000094A/es
Priority to ARP030100807A priority patent/AR038914A1/es
Priority to UY27712A priority patent/UY27712A1/es
Priority to US10/385,870 priority patent/US6858638B2/en
Publication of FR2836914A1 publication Critical patent/FR2836914A1/fr
Priority to MA27825A priority patent/MA27176A1/fr
Priority to ZA200406730A priority patent/ZA200406730B/en
Priority to IL163805A priority patent/IL163805A/en
Priority to TNP2004000175A priority patent/TNSN04175A1/fr
Priority to EC2004005286A priority patent/ECSP045286A/es
Priority to NO20044261A priority patent/NO20044261L/no
Priority to US10/963,880 priority patent/US7473701B2/en
Application granted granted Critical
Publication of FR2836914B1 publication Critical patent/FR2836914B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
FR0202996A 2002-03-11 2002-03-11 Indazoles substitues, compositions les contenant, procede de fabrication et utilisation Expired - Fee Related FR2836914B1 (fr)

Priority Applications (31)

Application Number Priority Date Filing Date Title
FR0202996A FR2836914B1 (fr) 2002-03-11 2002-03-11 Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
GT200300031A GT200300031A (es) 2002-03-11 2003-02-06 Indazoles substitutos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
PA20038566701A PA8566701A1 (es) 2002-03-11 2003-02-13 Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
TW092103799A TW200303863A (en) 2002-03-11 2003-02-24 Substituted indazoles, compositions comprising them, manufacturing process and use
SV2003001493A SV2003001493A (es) 2002-03-11 2003-03-03 Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
RU2004130280/04A RU2004130280A (ru) 2002-03-11 2003-03-07 Замещенные индазолы, обладающие притовораковой активностью
OA1200400236A OA12784A (fr) 2002-03-11 2003-03-07 Indazoles substutués avec une activité anticancéreuse.
CNB038058731A CN100369899C (zh) 2002-03-11 2003-03-07 具有抗癌活性的取代的吲唑
MXPA04008446A MXPA04008446A (es) 2002-03-11 2003-03-07 Indazoles sustituidos, con actividad anticancerosa.
HR20040825A HRP20040825A2 (en) 2002-03-11 2003-03-07 Indazoles substituted with an anti-cancerous activity
AU2003242808A AU2003242808B2 (en) 2002-03-11 2003-03-07 Indazoles substituted with an anti-cancerous activity
BR0308339-0A BR0308339A (pt) 2002-03-11 2003-03-07 Indazóis substituìdos com uma atividade anticancerosa
JP2003576408A JP4643910B2 (ja) 2002-03-11 2003-03-07 抗癌活性を有する置換インダゾール
PCT/FR2003/000751 WO2003078402A1 (fr) 2002-03-11 2003-03-07 Indazoles substitues avec une activite anticancereuse
CA002478540A CA2478540A1 (fr) 2002-03-11 2003-03-07 Indazoles substitues avec une activite anticancereuse
PE2003000232A PE20040071A1 (es) 2002-03-11 2003-03-07 Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
EP03744395A EP1487803A1 (fr) 2002-03-11 2003-03-07 Indazoles substitues avec une activite anticancereuse
PL03372389A PL372389A1 (en) 2002-03-11 2003-03-07 Indazoles substituted with an anti-cancerous activity
KR10-2004-7014298A KR20040091128A (ko) 2002-03-11 2003-03-07 항암 활성을 갖는 치환된 인다졸
IL16380503A IL163805A0 (en) 2002-03-11 2003-03-07 Indazoles substituted with an anti-cancerous activity
HN2003000094A HN2003000094A (es) 2002-03-11 2003-03-10 Indazoles subtituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
ARP030100807A AR038914A1 (es) 2002-03-11 2003-03-10 Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion para fabricar un medicamento
US10/385,870 US6858638B2 (en) 2002-03-11 2003-03-11 Substituted indazoles, compositions containing them, method of production and use
UY27712A UY27712A1 (es) 2002-03-11 2003-03-11 Indazoles sustituidos, composiciones que los contienen, procedimientos de fabricación y utilización
MA27825A MA27176A1 (fr) 2002-03-11 2004-08-12 Indazoles substitues avec une activite anticancereuse.
ZA200406730A ZA200406730B (en) 2002-03-11 2004-08-24 Indazole substituted with an anti-cancerous activity.
IL163805A IL163805A (en) 2002-03-11 2004-08-30 Transformed islands with anti-cancer activity
TNP2004000175A TNSN04175A1 (fr) 2002-03-11 2004-09-10 Indazoles substitues avec une activite anticancereuse
EC2004005286A ECSP045286A (es) 2002-03-11 2004-09-10 Indazoles sustituidos con una actividad anticancerosa
NO20044261A NO20044261L (no) 2002-03-11 2004-10-07 Indazoler substituerte med en anticanceros aktivitet
US10/963,880 US7473701B2 (en) 2002-03-11 2004-10-13 Substituted indazoles, compositions containing them, method of production and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0202996A FR2836914B1 (fr) 2002-03-11 2002-03-11 Indazoles substitues, compositions les contenant, procede de fabrication et utilisation

Publications (2)

Publication Number Publication Date
FR2836914A1 FR2836914A1 (fr) 2003-09-12
FR2836914B1 true FR2836914B1 (fr) 2008-03-14

Family

ID=27763684

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0202996A Expired - Fee Related FR2836914B1 (fr) 2002-03-11 2002-03-11 Indazoles substitues, compositions les contenant, procede de fabrication et utilisation

Country Status (29)

Country Link
US (2) US6858638B2 (enExample)
EP (1) EP1487803A1 (enExample)
JP (1) JP4643910B2 (enExample)
KR (1) KR20040091128A (enExample)
CN (1) CN100369899C (enExample)
AR (1) AR038914A1 (enExample)
AU (1) AU2003242808B2 (enExample)
BR (1) BR0308339A (enExample)
CA (1) CA2478540A1 (enExample)
EC (1) ECSP045286A (enExample)
FR (1) FR2836914B1 (enExample)
GT (1) GT200300031A (enExample)
HN (1) HN2003000094A (enExample)
HR (1) HRP20040825A2 (enExample)
IL (2) IL163805A0 (enExample)
MA (1) MA27176A1 (enExample)
MX (1) MXPA04008446A (enExample)
NO (1) NO20044261L (enExample)
OA (1) OA12784A (enExample)
PA (1) PA8566701A1 (enExample)
PE (1) PE20040071A1 (enExample)
PL (1) PL372389A1 (enExample)
RU (1) RU2004130280A (enExample)
SV (1) SV2003001493A (enExample)
TN (1) TNSN04175A1 (enExample)
TW (1) TW200303863A (enExample)
UY (1) UY27712A1 (enExample)
WO (1) WO2003078402A1 (enExample)
ZA (1) ZA200406730B (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2836914B1 (fr) * 2002-03-11 2008-03-14 Aventis Pharma Sa Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
GB0218625D0 (en) * 2002-08-10 2002-09-18 Astex Technology Ltd Pharmaceutical compounds
US7262200B2 (en) 2002-10-25 2007-08-28 Vertex Pharmaceuticals Incorporated Indazolinone compositions useful as kinase inhibitors
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
WO2005014554A1 (en) * 2003-08-08 2005-02-17 Astex Therapeutics Limited 1h-indazole-3-carboxamide compounds as mapkap kinase modulators
FR2864084B1 (fr) * 2003-12-17 2006-02-10 Aventis Pharma Sa Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
US7572914B2 (en) 2003-12-19 2009-08-11 Takeda Pharmaceutical Company Limited Kinase inhibitors
GB0330043D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
GB0330042D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
WO2005105788A1 (en) * 2004-04-23 2005-11-10 Takeda San Diego, Inc. Indole derivatives and use thereof as kinase inhibitors
WO2006023931A2 (en) 2004-08-18 2006-03-02 Takeda San Diego, Inc. Kinase inhibitors
BRPI0515931A (pt) * 2004-09-29 2008-08-12 Hoffmann La Roche compostos, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades e utilização desses compostos
EP1812439B2 (en) 2004-10-15 2017-12-06 Takeda Pharmaceutical Company Limited Kinase inhibitors
SE0402762D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Indazole sulphonamide derivatives
SE0402763D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Nitro indazole derivatives
CN101243051A (zh) * 2005-08-25 2008-08-13 霍夫曼-拉罗奇有限公司 p38 MAP激酶抑制剂及使用它的方法
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
WO2007089646A1 (en) 2006-01-31 2007-08-09 Array Biopharma Inc. Kinase inhibitors and methods of use thereof
JP2010505962A (ja) 2006-10-09 2010-02-25 武田薬品工業株式会社 キナーゼ阻害剤
EP2223925A1 (en) * 2006-10-09 2010-09-01 Takeda Pharmaceutical Company Limited Kinase inhibitors
WO2008063888A2 (en) * 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
FR2917735B1 (fr) * 2007-06-21 2009-09-04 Sanofi Aventis Sa Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique
JP5364875B2 (ja) * 2007-07-16 2013-12-11 アッヴィ・インコーポレイテッド タンパク質キナーゼ阻害薬としてのインダゾール類、ベンゾイソオキサゾール類およびベンゾイソチアゾール類
US20220315555A1 (en) 2009-05-26 2022-10-06 Abbvie Inc. Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
US9034875B2 (en) 2009-05-26 2015-05-19 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ES2546294T7 (es) * 2009-05-26 2024-06-06 Abbvie Ireland Unlimited Co Agentes inductores de la apoptosis para el tratamiento de cáncer y enfermedades inmunitarias y autoinmunitarias
US8546399B2 (en) 2009-05-26 2013-10-01 Abbvie Inc. Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
WO2011050245A1 (en) * 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
CN102247361B (zh) * 2010-05-20 2015-04-29 中国医学科学院药物研究所 5-硝基-1氢-吲唑-3-腈在制备药物中的应用
UA113500C2 (xx) 2010-10-29 2017-02-10 Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
KR20180059560A (ko) 2010-10-29 2018-06-04 애브비 인코포레이티드 아폽토시스―유도제를 포함하는 고체 분산체
WO2012071336A1 (en) 2010-11-23 2012-05-31 Abbott Laboratories Salts and crystalline forms of an apoptosis-inducing agent
RU2593231C2 (ru) 2010-11-23 2016-08-10 ЭббВи Айэленд Анлимитед Компани Способы лечения с использованием селективных ингибиторов bcl-2
US20140275082A1 (en) 2013-03-14 2014-09-18 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
CN107108556B (zh) 2014-11-03 2020-09-29 艾欧米制药有限公司 药用化合物
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
US11926596B2 (en) 2017-07-21 2024-03-12 Kadmon Corporation, Llc Inhibitors of Rho associated coiled-coil containing protein kinase
WO2019046467A1 (en) 2017-08-29 2019-03-07 Rutgers, The State University Of New Jersey INDAZOLES THERAPEUTIC
AU2022326463A1 (en) 2021-08-10 2024-02-22 Novartis Pharma Ag Compounds and compositions for treating conditions associated with sting activity
JP2025504415A (ja) * 2022-01-12 2025-02-12 アイエフエム デュー インコーポレイテッド Ｓｔｉｎｇ活性に関連する病態を治療するための化合物及び組成物
EP4488275A4 (en) 2022-03-04 2025-07-23 Shanghai Yingli Pharm Co Ltd COMPOUND CONTAINING A FIVE-MEMBERED HETEROAROMATIC RING STRUCTURE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
CN114605329B (zh) * 2022-03-28 2024-01-26 河南中医药大学 取代的吲唑甲酰胺或取代的氮杂吲唑甲酰胺类flt3抑制剂及其用途
CN119997982A (zh) 2022-09-09 2025-05-13 迈里克斯制药有限公司 包含nmt抑制剂的抗体药物偶联物及其用途
JP2026502949A (ja) 2022-12-30 2026-01-27 アヴィセンナ バイオサイエンシズ インコーポレイテッド アザインドールｒｏｃｋ阻害剤
WO2024254990A1 (zh) 2023-06-16 2024-12-19 上海璎黎药业有限公司 一种杂芳环结构化合物、其药物组合物及应用
AU2024392169A1 (en) * 2023-11-28 2026-06-11 Quantx Biosciences Us, Inc. Bicyclic heteroaryl compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS514505Y2 (enExample) 1971-02-13 1976-02-07
JPH061350B2 (ja) * 1985-07-26 1994-01-05 コニカ株式会社 ハロゲン化銀写真感光材料
NZ331941A (en) 1996-02-22 2000-04-28 Tularik Inc Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis
DE69724811T2 (de) * 1996-07-19 2004-04-08 Tularik, Inc., South San Francisco Pentafluorobenzensulfonamide und analoge
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase
AU1818400A (en) 1998-11-12 2000-05-29 Eli Lilly And Company Aryloxime linkers in the solid-phase synthesis of 3-aminobenzisoxazoles
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
KR100423899B1 (ko) * 2000-05-10 2004-03-24 주식회사 엘지생명과학 세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
WO2002083648A1 (fr) * 2001-04-16 2002-10-24 Eisai Co., Ltd. Nouveau compose a base de 1h-indazole
EP1403255A4 (en) 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
JP2004536113A (ja) * 2001-07-03 2004-12-02 カイロン コーポレイション チロシンキナーゼおよびセリン／スレオニンキナーゼのインヒビターとしてのインダゾールベンズイミダゾール化合物
WO2003024969A1 (en) 2001-09-14 2003-03-27 Merck & Co., Inc. Tyrosine kinase inhibitors
FR2836915B1 (fr) * 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
FR2836914B1 (fr) * 2002-03-11 2008-03-14 Aventis Pharma Sa Indazoles substitues, compositions les contenant, procede de fabrication et utilisation

Also Published As

Publication number Publication date
IL163805A0 (en) 2005-12-18
PE20040071A1 (es) 2004-02-13
AR038914A1 (es) 2005-02-02
US20040106667A1 (en) 2004-06-03
US7473701B2 (en) 2009-01-06
JP2005533004A (ja) 2005-11-04
ECSP045286A (es) 2004-10-26
JP4643910B2 (ja) 2011-03-02
CA2478540A1 (fr) 2003-09-25
SV2003001493A (es) 2003-07-10
US20050059722A1 (en) 2005-03-17
UY27712A1 (es) 2003-09-30
HN2003000094A (es) 2003-12-15
AU2003242808A1 (en) 2003-09-29
HRP20040825A2 (en) 2005-06-30
BR0308339A (pt) 2005-02-01
MA27176A1 (fr) 2005-01-03
KR20040091128A (ko) 2004-10-27
WO2003078402A1 (fr) 2003-09-25
TNSN04175A1 (fr) 2007-03-12
US6858638B2 (en) 2005-02-22
PA8566701A1 (es) 2003-12-10
NO20044261L (no) 2004-11-25
FR2836914A1 (fr) 2003-09-12
ZA200406730B (en) 2005-08-24
CN1642922A (zh) 2005-07-20
GT200300031A (es) 2006-05-26
CN100369899C (zh) 2008-02-20
PL372389A1 (en) 2005-07-25
MXPA04008446A (es) 2004-12-06
EP1487803A1 (fr) 2004-12-22
TW200303863A (en) 2003-09-16
AU2003242808B2 (en) 2008-09-18
IL163805A (en) 2009-08-03
RU2004130280A (ru) 2005-06-27
OA12784A (fr) 2006-07-10

Similar Documents

Publication Publication Date Title
FR2884821B1 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
EP1626717A4 (en) BENZIMIDAZOLE, COMPOSITIONS AND METHOD OF ADMINISTRATION CONTAINING SUCH COMPOUNDS
CY2019032I2 (el) (+)-2-[1-(3-αιθοξυ-4-μεθοξυφαινυλ)-2-μεθυλσουλφονυλαιθυλ]-4-ακετυλαμινoϊσoϊνδoλινo-1,3-διonη: μεθοδοι χρησης και συνθεσεις αυτης
EP1506786A4 (en) MEDICAL GHRELIN CONTAINING COMPOSITIONS
FR2878849B1 (fr) Indoles substitues, compositions les contenant, procede de fabrication et utilisation
EP1601760A4 (en) NANOPORES, METHOD OF THEIR USE, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR CHARACTERIZING BIOMOLECULES USING THEREOF
EP1539729A4 (en) NITROSED NON-TESTED OXIDE COMPOUNDS, COMPOSITIONS, AND APPLICATION METHODS
EP1545206A4 (en) COMPOSITIONS AND PRODUCTS CONTAINING ENANTIOMER EQUOL, AND METHOD FOR THE PRODUCTION THEREOF
MX285679B (es) Composicion de resina absorbente de agua y metodo de produccion de la misma.
EP1569915A4 (en) SPIROCYCLIC UREA, COMPOSITIONS CONTAINING THESE COMPOUNDS AND METHOD OF USE
EP1539730A4 (en) NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD FOR THEIR APPLICATION
EP1663255A4 (en) WITHANAMID AND WITHANOLID COMPOSITIONS AND APPLICATION METHOD THEREFOR
ITMI20011061A0 (it) Composizioni fluoroelastomeriche
IS7413A (is) Nýjar 1,2,3,-setnar indólísín afleiður, hindrar af FGFS, aðferð við framleiðslu á þeim og lyfjafræðilegar samsetningar sem innihalda þau
ITMI20011060A0 (it) Composizioni fluoroelastomeriche
DE10393672D2 (de) Verfahren zur Bereitstellung von Ressourchen in Kommunikations-Netzwerken
EP1651231A4 (en) DIPHENYL-SUBSTITUTED CYCLOALKANES, COMPOSITIONS AND METHODS OF APPLYING THESE COMPOUNDS
EP1566446A4 (en) BETA-1,4-MANNOBIOSE-CONTAINING COMPOSITION
ITMI20011059A0 (it) Composizioni fluoroelastomeriche
FR2881426B1 (fr) Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation
MA29026B1 (fr) Indoles substitues, compositions les contenant, procede de fabrication et utilisation
FI20031472A0 (fi) Menetelmä verkkosuuntaajan yhteydessä ja verkkosuuntaaja
FR2881742B1 (fr) Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation
FR2855825B1 (fr) Produits aryl-heteroaromatiques, compositions les contenant et utilisation
EP1645551A4 (en) DIELECTRIC CERAMIC COMPOSITION, MANUFACTURING METHOD, DIELECTRIC CERAMICS THEREFOR AND MULTILAYER CERAMIC COMPONENT

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20151130